Hills Bank & Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.16M | Buy |
30,320
+2,402
| +9% | +$92.2K | 0.07% | 138 |
|
2025
Q1 | $1.08M | Buy |
27,918
+1,234
| +5% | +$47.8K | 0.08% | 134 |
|
2024
Q4 | $902K | Buy |
26,684
+1,386
| +5% | +$46.9K | 0.07% | 146 |
|
2024
Q3 | $1.03M | Sell |
25,298
-1,131
| -4% | -$46.2K | 0.08% | 140 |
|
2024
Q2 | $1.02M | Buy |
26,429
+2,954
| +13% | +$114K | 0.08% | 135 |
|
2024
Q1 | $1.01M | Buy |
23,475
+2,191
| +10% | +$93.9K | 0.09% | 134 |
|
2023
Q4 | $789K | Buy |
21,284
+1,429
| +7% | +$53K | 0.08% | 138 |
|
2023
Q3 | $720K | Buy |
19,855
+2,092
| +12% | +$75.8K | 0.08% | 131 |
|
2023
Q2 | $633K | Buy |
17,763
+2,709
| +18% | +$96.5K | 0.08% | 128 |
|
2023
Q1 | $536K | Buy |
15,054
+7,249
| +93% | +$258K | 0.07% | 137 |
|
2022
Q4 | $274K | Buy |
+7,805
| New | +$274K | 0.04% | 178 |
|